Sei Investments Co. trimmed its stake in Danaher Corporation (NYSE:DHR) by 23.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 282,687 shares of the conglomerate’s stock after selling 88,419 shares during the period. Sei Investments Co.’s holdings in Danaher Corporation were worth $24,249,000 as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Danaher Corporation by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 41,488,407 shares of the conglomerate’s stock worth $3,501,206,000 after buying an additional 520,776 shares during the period. BlackRock Inc. increased its stake in Danaher Corporation by 3.2% during the 2nd quarter. BlackRock Inc. now owns 39,201,798 shares of the conglomerate’s stock worth $3,308,239,000 after buying an additional 1,233,876 shares during the period. FMR LLC increased its stake in Danaher Corporation by 0.9% during the 2nd quarter. FMR LLC now owns 19,624,350 shares of the conglomerate’s stock worth $1,656,100,000 after buying an additional 183,183 shares during the period. Parnassus Investments CA increased its stake in Danaher Corporation by 0.3% during the 3rd quarter. Parnassus Investments CA now owns 9,796,584 shares of the conglomerate’s stock worth $840,351,000 after buying an additional 29,381 shares during the period. Finally, Geode Capital Management LLC increased its stake in Danaher Corporation by 6.0% during the 1st quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after buying an additional 329,458 shares during the period. 75.56% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Danaher Corporation (DHR) Shares Sold by Sei Investments Co.” was first reported by Week Herald and is the property of of Week Herald. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://weekherald.com/2017/11/23/danaher-corporation-dhr-shares-sold-by-sei-investments-co.html.
Danaher Corporation (NYSE:DHR) opened at $93.76 on Thursday. Danaher Corporation has a twelve month low of $76.27 and a twelve month high of $94.24. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00. The stock has a market cap of $65,512.09, a price-to-earnings ratio of 24.21, a PEG ratio of 2.24 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The business had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the prior year, the business posted $0.87 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. sell-side analysts expect that Danaher Corporation will post 3.99 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s payout ratio is 16.52%.
In other news, CFO Daniel L. Comas sold 88,184 shares of the company’s stock in a transaction on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total value of $8,026,507.68. Following the completion of the transaction, the chief financial officer now owns 227,816 shares in the company, valued at approximately $20,735,812.32. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider William King sold 43,688 shares of the stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the sale, the insider now owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The disclosure for this sale can be found here. In the last 90 days, insiders sold 317,498 shares of company stock valued at $28,838,801. Company insiders own 12.20% of the company’s stock.
Several equities research analysts recently weighed in on DHR shares. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. Credit Suisse Group upped their target price on shares of Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. Finally, Robert W. Baird upped their target price on shares of Danaher Corporation from $87.00 to $97.00 and gave the stock an “outperform” rating in a research note on Friday, October 20th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $93.31.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.